Concepedia

Frederick Calo

FC

Statistics

Publications

12

Citations

292

H-Index

11

Active since

2008

Affiliations

Imperial College London(Current)

Pfizer (United Kingdom)

Eli Lilly (United States)

Eli Lilly (United Kingdom)

Frederick Calo is an author at Imperial College London specializing in medicinal chemistry, pharmacy, and drug discovery.

Publications per year

2008–2014

12

Publications

12

Total Synthesis of Aigialomycin D using a One-Pot Ketene Generation−Trapping−Aromatization Sequence

Frederick Calo, Jeffery Richardson, Anthony G. M. Barrett · Organic Letters · 2009 · 64 citations

, , +11

Biomimetic Total Synthesis of Angelicoin A and B via a Palladium-Catalyzed Decarboxylative Prenylation-Aromatization Sequence

Katie Anderson, Frederick Calo, Toni Pfaffeneder et al. · Organic Letters · 2011 · 34 citations

, , +6

Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase

Christopher N. Johnson, Christophe Adelinet, Valério Berdini et al. · ACS Medicinal Chemistry Letters · 2014 · 31 citations · Full text

, , +17

Total Syntheses of Angelicoin A, Hericenone J, and Hericenol A via Migratory Prenyl- and Geranylation–Aromatization Sequences

J. M. Cordes, Frederick Calo, Katie Anderson et al. · The Journal of Organic Chemistry · 2011 · 29 citations

, , +12

Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection

Thien-Duc Tran, David C. Pryde, Peter Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 27 citations · Full text

, , +10

1–5 of 12